Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /
23/05/2024 17:11:52 | Var. - | Volume | Denaro06:00:06 | Lettera06:00:06 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
7.970CHF | - | 520 Fatturato: 4,135.590 |
-Quantità in denaro: - | -Quantità in lettera: - | 912.21 mill.CHF | - | - |
GlobeNewswire
31/08
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
28/08
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Car...
GlobeNewswire
21/08
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
GlobeNewswire
14/08
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
14/08
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13/08
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13/08
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13/08
Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update
GlobeNewswire
12/08
Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as Firs...
GlobeNewswire
08/08
Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/08
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
GlobeNewswire
08/08
Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Pro...
GlobeNewswire
08/08
Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
06/08
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update